Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Gillissen MA"'
Autor:
Tromp SAM; Department of Pediatric Immunology, Rheumatology and Infectious Disease, Emma Children's Hospital.; Department of Experimental Immunology, Amsterdam Institute for Infection and Immunity., Gillissen MA; Department of Hematology, and., Bernelot Moens SJ; Department of Hematology, and., van Leeuwen EMM; Department of Experimental Immunology, Amsterdam Institute for Infection and Immunity., Jansen MH; Department of Experimental Immunology, Amsterdam Institute for Infection and Immunity., Koens L; Department of Pathology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Rutten CE; Department of Hematology, and., Kuijpers TW; Department of Pediatric Immunology, Rheumatology and Infectious Disease, Emma Children's Hospital.; Department of Experimental Immunology, Amsterdam Institute for Infection and Immunity.
Publikováno v:
Blood advances [Blood Adv] 2022 Aug 09; Vol. 6 (15), pp. 4501-4505.
Autor:
de Jong G; AIMM Therapeutics, Meibergdreef 59, 1105 BA, Amsterdam, The Netherlands.; Department of Hematology, Amsterdam UMC, Location AMC, Amsterdam, The Netherlands.; Cancer Center Amsterdam (CCA), Amsterdam, The Netherlands.; Amsterdam Infection and Immunity Institute (AI&II), Amsterdam, The Netherlands., Bartels L; AIMM Therapeutics, Meibergdreef 59, 1105 BA, Amsterdam, The Netherlands.; Amsterdam Infection and Immunity Institute (AI&II), Amsterdam, The Netherlands., Kedde M; AIMM Therapeutics, Meibergdreef 59, 1105 BA, Amsterdam, The Netherlands., Verdegaal EME; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands., Gillissen MA; AIMM Therapeutics, Meibergdreef 59, 1105 BA, Amsterdam, The Netherlands.; Department of Hematology, Amsterdam UMC, Location AMC, Amsterdam, The Netherlands.; Cancer Center Amsterdam (CCA), Amsterdam, The Netherlands.; Amsterdam Infection and Immunity Institute (AI&II), Amsterdam, The Netherlands., Levie SE; AIMM Therapeutics, Meibergdreef 59, 1105 BA, Amsterdam, The Netherlands., Cercel MG; AIMM Therapeutics, Meibergdreef 59, 1105 BA, Amsterdam, The Netherlands., van Hal-van Veen SE; AIMM Therapeutics, Meibergdreef 59, 1105 BA, Amsterdam, The Netherlands., Fatmawati C; AIMM Therapeutics, Meibergdreef 59, 1105 BA, Amsterdam, The Netherlands., van de Berg D; AIMM Therapeutics, Meibergdreef 59, 1105 BA, Amsterdam, The Netherlands., Yasuda E; AIMM Therapeutics, Meibergdreef 59, 1105 BA, Amsterdam, The Netherlands., Claassen YB; AIMM Therapeutics, Meibergdreef 59, 1105 BA, Amsterdam, The Netherlands., Bakker AQ; AIMM Therapeutics, Meibergdreef 59, 1105 BA, Amsterdam, The Netherlands., van der Burg SH; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands., Schotte R; AIMM Therapeutics, Meibergdreef 59, 1105 BA, Amsterdam, The Netherlands., Villaudy J; AIMM Therapeutics, Meibergdreef 59, 1105 BA, Amsterdam, The Netherlands., Spits H; AIMM Therapeutics, Meibergdreef 59, 1105 BA, Amsterdam, The Netherlands.; Amsterdam Infection and Immunity Institute (AI&II), Amsterdam, The Netherlands.; Department of Experimental Immunology, Amsterdam UMC, Location AMC, Amsterdam, The Netherlands., Hazenberg MD; Department of Hematology, Amsterdam UMC, Location AMC, Amsterdam, The Netherlands.; Cancer Center Amsterdam (CCA), Amsterdam, The Netherlands.; Amsterdam Infection and Immunity Institute (AI&II), Amsterdam, The Netherlands.; Department of Hematopoiesis, Sanquin Research, Amsterdam, The Netherlands., van Helden PM; AIMM Therapeutics, Meibergdreef 59, 1105 BA, Amsterdam, The Netherlands. pmvanhelden@aimmtherapeutics.com., Wagner K; AIMM Therapeutics, Meibergdreef 59, 1105 BA, Amsterdam, The Netherlands.
Publikováno v:
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2021 Jun; Vol. 70 (6), pp. 1569-1581. Date of Electronic Publication: 2020 Nov 23.
Tumour-reactive B cells and antibody responses after allogeneic haematopoietic cell transplantation.
Autor:
de Jong G; Department of Haematology, Amsterdam UMC, Amsterdam, The Netherlands.; AIMM Therapeutics, Amsterdam, The Netherlands.; Cancer Center Amsterdam and Amsterdam Infection and Immunity Institute, Amsterdam, The Netherlands., Gillissen MA; Department of Haematology, Amsterdam UMC, Amsterdam, The Netherlands.; Cancer Center Amsterdam and Amsterdam Infection and Immunity Institute, Amsterdam, The Netherlands., Spits H; Department of Experimental Immunology, Amsterdam UMC, Amsterdam, The Netherlands., Hazenberg MD; Department of Haematology, Amsterdam UMC, Amsterdam, The Netherlands.; Cancer Center Amsterdam and Amsterdam Infection and Immunity Institute, Amsterdam, The Netherlands.; Department of Experimental Immunohematology, Sanquin Research, Amsterdam, The Netherlands.
Publikováno v:
Immuno-oncology technology [Immunooncol Technol] 2020 Jul 23; Vol. 7, pp. 15-22. Date of Electronic Publication: 2020 Jul 23 (Print Publication: 2020).
Autor:
Bartels L; AIMM Therapeutics, Amsterdam, the Netherlands.; Department of Experimental Immunology, Amsterdam University Medical Center, Location AMC, Amsterdam, the Netherlands.; Amsterdam Infection and Immunity Institute, Amsterdam, the Netherlands., de Jong G; AIMM Therapeutics, Amsterdam, the Netherlands.; Department of Experimental Immunology, Amsterdam University Medical Center, Location AMC, Amsterdam, the Netherlands.; Amsterdam Infection and Immunity Institute, Amsterdam, the Netherlands.; Cancer Center Amsterdam, Amsterdam, the Netherlands.; Department of Hematology, Amsterdam University Medical Center, Location AMC, Amsterdam, the Netherlands., Gillissen MA; AIMM Therapeutics, Amsterdam, the Netherlands.; Department of Experimental Immunology, Amsterdam University Medical Center, Location AMC, Amsterdam, the Netherlands.; Amsterdam Infection and Immunity Institute, Amsterdam, the Netherlands.; Cancer Center Amsterdam, Amsterdam, the Netherlands.; Department of Hematology, Amsterdam University Medical Center, Location AMC, Amsterdam, the Netherlands., Yasuda E; AIMM Therapeutics, Amsterdam, the Netherlands., Kattler V; AIMM Therapeutics, Amsterdam, the Netherlands., Bru C; AIMM Therapeutics, Amsterdam, the Netherlands., Fatmawati C; AIMM Therapeutics, Amsterdam, the Netherlands., van Hal-van Veen SE; AIMM Therapeutics, Amsterdam, the Netherlands., Cercel MG; AIMM Therapeutics, Amsterdam, the Netherlands., Moiset G; AIMM Therapeutics, Amsterdam, the Netherlands.; Department of Experimental Immunology, Amsterdam University Medical Center, Location AMC, Amsterdam, the Netherlands.; Amsterdam Infection and Immunity Institute, Amsterdam, the Netherlands.; Cancer Center Amsterdam, Amsterdam, the Netherlands.; Department of Hematology, Amsterdam University Medical Center, Location AMC, Amsterdam, the Netherlands., Bakker AQ; AIMM Therapeutics, Amsterdam, the Netherlands., van Helden PM; AIMM Therapeutics, Amsterdam, the Netherlands., Villaudy J; AIMM Therapeutics, Amsterdam, the Netherlands., Hazenberg MD; Department of Experimental Immunology, Amsterdam University Medical Center, Location AMC, Amsterdam, the Netherlands.; Amsterdam Infection and Immunity Institute, Amsterdam, the Netherlands.; Cancer Center Amsterdam, Amsterdam, the Netherlands.; Department of Hematology, Amsterdam University Medical Center, Location AMC, Amsterdam, the Netherlands., Spits H; AIMM Therapeutics, Amsterdam, the Netherlands.; Department of Experimental Immunology, Amsterdam University Medical Center, Location AMC, Amsterdam, the Netherlands.; Amsterdam Infection and Immunity Institute, Amsterdam, the Netherlands., Wagner K; AIMM Therapeutics, Amsterdam, the Netherlands. kwagner@aimmtherapeutics.com.
Publikováno v:
Cancer research [Cancer Res] 2019 Jul 01; Vol. 79 (13), pp. 3372-3382. Date of Electronic Publication: 2019 May 07.
Autor:
Gillissen MA; AIMM Therapeutics and.; Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands., Kedde M; AIMM Therapeutics and., Jong G; Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands., Moiset G; AIMM Therapeutics and.; Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands., Yasuda E; AIMM Therapeutics and., Levie SE; AIMM Therapeutics and., Bakker AQ; AIMM Therapeutics and., Claassen YB; AIMM Therapeutics and., Wagner K; AIMM Therapeutics and., Böhne M; AIMM Therapeutics and., Hensbergen PJ; Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands; and., Speijer D; Department of Medical Biochemistry, Academic Medical Center, Amsterdam, The Netherlands., van Helden PM; AIMM Therapeutics and., Beaumont T; AIMM Therapeutics and., Spits H; AIMM Therapeutics and., Hazenberg MD; Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands.
Publikováno v:
Blood [Blood] 2018 Jan 04; Vol. 131 (1), pp. 131-143. Date of Electronic Publication: 2017 Oct 23.
Autor:
Gillissen MA; AIMM Therapeutics, Amsterdam, The Netherlands.; Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands., de Jong G; AIMM Therapeutics, Amsterdam, The Netherlands.; Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands., Kedde M; AIMM Therapeutics, Amsterdam, The Netherlands., Yasuda E; AIMM Therapeutics, Amsterdam, The Netherlands., Levie SE; AIMM Therapeutics, Amsterdam, The Netherlands., Moiset G; AIMM Therapeutics, Amsterdam, The Netherlands., Hensbergen PJ; Center for Proteomics and Metabolomics, University Medical Center, Leiden, The Netherlands; and., Bakker AQ; AIMM Therapeutics, Amsterdam, The Netherlands., Wagner K; AIMM Therapeutics, Amsterdam, The Netherlands., Villaudy J; AIMM Therapeutics, Amsterdam, The Netherlands., van Helden PM; AIMM Therapeutics, Amsterdam, The Netherlands., Spits H; AIMM Therapeutics, Amsterdam, The Netherlands.; Department of Experimental Immunology, Academic Medical Center, Amsterdam, The Netherlands., Hazenberg MD; Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands.; Department of Experimental Immunology, Academic Medical Center, Amsterdam, The Netherlands.
Publikováno v:
Blood advances [Blood Adv] 2017 Aug 18; Vol. 1 (19), pp. 1551-1564. Date of Electronic Publication: 2017 Aug 18 (Print Publication: 2017).
Autor:
Gillissen MA; AIMM Therapeutics, Academic Medical Center, Amsterdam, The Netherlands.; Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands., de Jong G; AIMM Therapeutics, Academic Medical Center, Amsterdam, The Netherlands.; Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands., Levie SE; AIMM Therapeutics, Academic Medical Center, Amsterdam, The Netherlands., Yasuda E; AIMM Therapeutics, Academic Medical Center, Amsterdam, The Netherlands., Bakker AQ; AIMM Therapeutics, Academic Medical Center, Amsterdam, The Netherlands., Evers LM; Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands., Pals ST; Department of Pathology, Academic Medical Center, Amsterdam, The Netherlands., Huisman C; Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands., van Helden PM; AIMM Therapeutics, Academic Medical Center, Amsterdam, The Netherlands., Spits H; AIMM Therapeutics, Academic Medical Center, Amsterdam, The Netherlands., Hazenberg MD; Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands.
Publikováno v:
Bone marrow transplantation [Bone Marrow Transplant] 2016 Sep; Vol. 51 (9), pp. 1245-8. Date of Electronic Publication: 2016 Apr 18.
Autor:
Gillissen MA; AIMM Therapeutics, Academic Medical Center, Amsterdam, The Netherlands; Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands., Yasuda E; AIMM Therapeutics, Academic Medical Center, Amsterdam, The Netherlands., de Jong G; AIMM Therapeutics, Academic Medical Center, Amsterdam, The Netherlands; Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands., Levie SE; AIMM Therapeutics, Academic Medical Center, Amsterdam, The Netherlands., Go D; AIMM Therapeutics, Academic Medical Center, Amsterdam, The Netherlands., Spits H; AIMM Therapeutics, Academic Medical Center, Amsterdam, The Netherlands., van Helden PM; AIMM Therapeutics, Academic Medical Center, Amsterdam, The Netherlands., Hazenberg MD; Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands. Electronic address: m.d.hazenberg@amc.nl.
Publikováno v:
Journal of immunological methods [J Immunol Methods] 2016 Jul; Vol. 434, pp. 16-23. Date of Electronic Publication: 2016 Apr 13.
Autor:
Gillissen MA; Institute of Complex Molecular Systems, Laboratory of Macromolecular and Organic Chemistry, Eindhoven University of Technology , P.O. Box 513, 5600 MB, Eindhoven, The Netherlands., Koenigs MM, Spiering JJ, Vekemans JA, Palmans AR, Voets IK, Meijer EW
Publikováno v:
Journal of the American Chemical Society [J Am Chem Soc] 2014 Jan 08; Vol. 136 (1), pp. 336-43. Date of Electronic Publication: 2013 Dec 19.
Autor:
Mes T; Institute for Complex Molecular Systems, Laboratory of Macromolecular and Organic Chemistry, Eindhoven University of Technology, PO Box 513, 5600 MB Eindhoven, The Netherlands., Cantekin S, Balkenende DW, Frissen MM, Gillissen MA, De Waal BF, Voets IK, Meijer EW, Palmans AR
Publikováno v:
Chemistry (Weinheim an der Bergstrasse, Germany) [Chemistry] 2013 Jun 24; Vol. 19 (26), pp. 8642-9. Date of Electronic Publication: 2013 May 06.